ART to be Present at the Fourth Annual Meeting of the Society for Molecular Imaging in Cologne, Germany.MONTREAL -- ART Advanced Research Technologies Inc. (TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension :ARA Ara or Arrah (both: ŭ`rə), city (1991 pop. 157,082), Bihar state, NE India, on the Son Canal. A major road and rail junction, it is the administrative center for a district that produces grain, sugarcane, and oilseed. ) Venue will Provide an Ideal Opportunity to Showcase New Applications of the eXplore Optix ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce its participation at the 4th Annual Meeting of the Society of Molecular Imaging (SMI (1) (Storage Management Initiative) The initiative developed by the SNIA in 2003 to create a single standard interface for storage management technologies used by multiple vendors and networking communities. ), being held at the Gurzenich Congress Center, in Cologne, Germany, from September 7 to 10, 2005. At the SMI conference, ART's sales and R&D teams will be joined by their GE Healthcare GE Healthcare is a $18 billion (USD) unit of General Electric (GE). It employs more than 46,000 people worldwide and is headquartered in Chalfont St. Giles, Buckinghamshire, United Kingdom. GE Healthcare is the first GE business segment headquartered outside the United States. partner to showcase the new eXplore Optix multi-wavelength system during a special User Group Meeting. The User Group Meeting will include presentations by many users and experts in the optical molecular imaging sector, who will be demonstrating new developments and applications in preclinical research using the eXplore Optix system. "ART will be showcasing a strong presence at this fourth meeting of the SMI, and will use this opportunity to give concrete demonstrations on the competitive advantages by ART's eXplore Optix system," said Micheline Bouchard, ART's President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. ."Recent sales performance and our backlog confirm the growing adoption of the new multiwavelength eXplore Optix system by the research community," added Ms. Bouchard. In addition, ART will be at the event as an exhibitor in the GE Healthcare booth (#23), and will present eXplore Optix(TM), a pre-clinical optical molecular imager designed to provide in vivo in vivo /in vi·vo/ (ve´vo) [L.] within the living body. in vi·vo adj. Within a living organism. in vivo adv. biodistribution and pharmacokinetics data, at the booth located in the Gurzenich Congress Center. About ART ART Advanced Research Technologies Inc. is a leader in optical molecular imaging products for the healthcare and pharmaceutical industries. ART has developed two products based on its innovative technology. The first is eXplore Optix(TM), a molecular imaging device designed for monitoring physiological changes in living systems at the preclinical study phases of new drugs.eXplore Optix(TM) is distributed by GE Healthcare and is used by industry and academic leaders worldwide to bring new and better treatments to patients faster. The second is SoftScan(R), a medical imaging device designed to improve the diagnosis and treatment of breast cancer. ART is commercializing its products in a global strategic alliance with GE Healthcare, a world leader in mammography mammography, diagnostic procedure that uses low-dose X rays to detect abnormalities in the breasts. The early diagnosis of breast cancer made possible by the routine use of mammography for screening women increases a woman's treatment alternatives and improves her and imaging. ART's shares are listed on the TSX under the ticker symbol Ticker Symbol An arrangement of characters (usually letters) representing a particular security listed on an exchange or otherwise traded publicly. When a company issues securities to the public marketplace, it selects an available ticker symbol for its securities which investors ARA. Visit ART online at www.art.ca This press release may contain forward-looking statements subject to risks and uncertainties that would cause actual events to differ materially from expectations. These risks and uncertainties are described in ART Advanced Research Technologies Inc.'s regulatory filings with Canadian Securities Commissions and the Securities and Exchange Commission in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . ART ADVANCED RESEARCH TECHNOLOGIES INC. (TSX:ARA) |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion